Camurus AB (publ) (STO:CAMX)
Sweden · Delayed Price · Currency is SEK 503.00
-3.00 (-0.59%)
At close: Feb 27, 2026
Camurus AB Market Cap
Camurus AB has a market cap or net worth of 30.03 billion as of February 27, 2026. Its market cap has decreased by -12.97% in one year.
Market Cap
30.03B
Enterprise Value
26.41B
Revenue
2.27B
Ranking
n/a
PE Ratio
41.03
Stock Price
503.00
Market Cap Chart
Since December 3, 2015, Camurus AB's market cap has increased from 1.66B to 30.03B, an increase of 1,704.73%. That is a compound annual growth rate of 32.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 30.03B | -18.27% |
| Dec 30, 2025 | 36.74B | 10.34% |
| Dec 30, 2024 | 33.30B | 11.26% |
| Dec 29, 2023 | 29.93B | 113.76% |
| Dec 30, 2022 | 14.00B | 69.32% |
| Dec 30, 2021 | 8.27B | -18.21% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioArctic AB | 28.21B |
| Hansa Biopharma AB | 3.33B |
| Saniona AB | 3.16B |
| Vicore Pharma Holding AB | 2.94B |
| Flerie AB | 2.84B |
| Diamyd Medical AB | 2.15B |
| Egetis Therapeutics AB | 1.84B |
| BioInvent International AB | 1.73B |